You are here

  • Home
  • Archive
  • Volume 102, Issue 2
  • Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye

Article info

Article menu
Download PDFPDF
Clinical science
Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye

Authors

  • Ido D Fabian Ocular Oncology Service, Moorfields Eye Hospital, London, UK Retinoblastoma Service, Royal London Hospital, London, UK Ocular Oncology Service, Goldschleger Eye Institute, Sheba Medical Center, Tel-Aviv University, Tel Aviv, Israel PubMed articlesGoogle scholar articles
  • Andrew W Stacey Ocular Oncology Service, Moorfields Eye Hospital, London, UK Retinoblastoma Service, Royal London Hospital, London, UK Department of Ophthalmology, University of Washington, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • Kenneth C Johnson Retinoblastoma Service, Royal London Hospital, London, UK PubMed articlesGoogle scholar articles
  • Tanzina Chowdhury Retinoblastoma Service, Royal London Hospital, London, UK Department of Paediatric Oncology, Great Ormond Street Hospital, London, UK PubMed articlesGoogle scholar articles
  • Catriona Duncan Retinoblastoma Service, Royal London Hospital, London, UK Department of Paediatric Oncology, Great Ormond Street Hospital, London, UK PubMed articlesGoogle scholar articles
  • M Ashwin Reddy Retinoblastoma Service, Royal London Hospital, London, UK PubMed articlesGoogle scholar articles
  • Mandeep S Sagoo Ocular Oncology Service, Moorfields Eye Hospital, London, UK Retinoblastoma Service, Royal London Hospital, London, UK University College London, Institute of Ophthalmology, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Ido D Fabian, Ocular Oncology Service, Moorfields Eye Hospital, 162 City Road, London EC1V 2PD, UK; didifabian{at}gmail.com
View Full Text

Citation

Fabian ID, Stacey AW, Johnson KC, et al
Primary enucleation for group D retinoblastoma in the era of systemic and targeted chemotherapy: the price of retaining an eye
British Journal of Ophthalmology 2018;102:265-271.

Publication history

  • Received April 19, 2017
  • Revised May 24, 2017
  • Accepted May 25, 2017
  • First published June 28, 2017.
Online issue publication 
January 24, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.